These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 13648510)

  • 41. [Elimination and retention of various polyvinylpyrrolidone types in the body].
    AMMON R; DEPNER E
    Z Gesamte Exp Med; 1957; 128(6):607-28. PubMed ID: 13456703
    [No Abstract]   [Full Text] [Related]  

  • 42. Long-term studies on the effect of polyvinylpyrrolidone retention in human patients.
    ALTEMEIER WA; SCHIFF L; GALL EA; GIUSEFFI J; HAMILTON D; FREIMAN D; BRAUNSTEIN H
    Surg Forum; 1953 Oct; 4():724-30. PubMed ID: 13187374
    [No Abstract]   [Full Text] [Related]  

  • 43. [Behavior of low molecular collidone in blood & urine in glomerulonephritis].
    SCHUBERT R
    Medizinische; 1958 Aug; 33-34():1248-52. PubMed ID: 13577353
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of channeling agents on the release pattern of theophylline from kollidon SR based matrix tablets.
    Ibn Razzak MS; Khan F; Hossain M; Khan MZ; Azad MA; Reza MS
    Pak J Pharm Sci; 2009 Jul; 22(3):303-7. PubMed ID: 19553179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Study of the urinary elimination of polyvinylpyrrolidone by means of perfusion of the isolated kidney and with intact dogs].
    BESSE JH
    Therapie; 1954; 9(6):685-90. PubMed ID: 14373612
    [No Abstract]   [Full Text] [Related]  

  • 46. Dissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers.
    Friedrich H; Fussnegger B; Kolter K; Bodmeier R
    Eur J Pharm Biopharm; 2006 Feb; 62(2):171-7. PubMed ID: 16275049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Retention symptoms of periston in man].
    HUSSELMANN H
    Klin Wochenschr; 1952 Sep; 30(33-34):801-8. PubMed ID: 13001112
    [No Abstract]   [Full Text] [Related]  

  • 48. [The transfer of large molecules from the blood into the bile and hepatic lymph in the guinea-pig. Study on polyvinylpyrrolidone-I-131].
    CHENDEROVITCH J; PHOCAS E; TROUPEL S; RENAULT H; CAROLI J
    Rev Fr Etud Clin Biol; 1961 May; 6():470-2. PubMed ID: 13692780
    [No Abstract]   [Full Text] [Related]  

  • 49. [The influence of kollidon on the content and on some reactions of blood protein bodies].
    ZAPP E
    Ann Univ Sarav Med; 1959; 7():155-6. PubMed ID: 13856499
    [No Abstract]   [Full Text] [Related]  

  • 50. Kollidon SR colloidal particles as vehicles for oral morphine delivery in pain treatment.
    Arias JL; Gómez-Gallo A; Delgado AV; Ruiz MA
    Colloids Surf B Biointerfaces; 2009 May; 70(2):207-12. PubMed ID: 19167868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carcinogenicity and chronic toxicity of copovidone (Kollidon VA 64) in Wistar rats and Beagle dogs.
    Mellert W; Deckardt K; Gembardt C; Hildebrand B; Schulte S
    Food Chem Toxicol; 2004 Oct; 42(10):1573-87. PubMed ID: 15304304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Tests of dye stuffs for kollidon infusions].
    OSTERTAG B; SCHUBERT R; FRIZ M
    Klin Wochenschr; 1951 Mar; 29(9-10):198-9. PubMed ID: 14825789
    [No Abstract]   [Full Text] [Related]  

  • 53. [Influence of Kollidon of various molecular weights on the separation process in blood. Remarks on ambulatory fresh plasma collection].
    HEINEN W; LOOSEN H; HEINEN H
    Arztl Wochensch; 1951 Apr; 6(17):388-92. PubMed ID: 14829363
    [No Abstract]   [Full Text] [Related]  

  • 54. The immobilization of gossypol derivative on N-polyvinylpyrrolidone increases its water solubility and modifies membrane-active properties.
    Ionov M; Gordiyenko N; Olchowik E; Baram N; Zijaev K; Salakhutdinov B; Bryszewska M; Zamaraeva M
    J Med Chem; 2009 Jul; 52(14):4119-25. PubMed ID: 19603832
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enzyme-purification and catalytic transformations in a microstructured PASSflow reactor using a new tyrosine-based Ni-NTA linker system attached to a polyvinylpyrrolidinone-based matrix.
    Dräger G; Kiss C; Kunz U; Kirschning A
    Org Biomol Chem; 2007 Nov; 5(22):3657-64. PubMed ID: 17971995
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Localized cutaneous polyvinylpyrrolidone storage disease mimicking cheilitis granulomatosa.
    Chi CC; Wang SH; Kuo TT
    J Cutan Pathol; 2006 Jun; 33(6):454-7. PubMed ID: 16776723
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Friction and wear behavior of poly(vinyl alcohol)/poly(vinyl pyrrolidone) hydrogels for articular cartilage replacement.
    Katta JK; Marcolongo M; Lowman A; Mansmann KA
    J Biomed Mater Res A; 2007 Nov; 83(2):471-9. PubMed ID: 17492689
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fast dispersible/slow releasing ibuprofen tablets.
    Fini A; Bergamante V; Ceschel GC; Ronchi C; de Moraes CA
    Eur J Pharm Biopharm; 2008 May; 69(1):335-41. PubMed ID: 18182280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of oropharyngeal decontamination by povidone-iodine on ventilator-associated pneumonia in patients with head trauma.
    Seguin P; Tanguy M; Laviolle B; Tirel O; Mallédant Y
    Crit Care Med; 2006 May; 34(5):1514-9. PubMed ID: 16540962
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mineralization of radiation-crosslinked polyvinyl alcohol/polyvinyl pyrrolidone hydrogels.
    ; Hill DJ; Whittaker AK
    J Biomed Mater Res A; 2007 Nov; 83(2):354-61. PubMed ID: 17450575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.